KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other financing activities: 2009-2022

Historic Other financing activities for Sarepta Therapeutics (SRPT) over the last 11 years, with Dec 2022 value amounting to $716,000.

  • Sarepta Therapeutics' Other financing activities fell 61.31% to $554,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $6.9 million, marking a year-over-year decrease of 4.65%. This contributed to the annual value of $716,000 for FY2022, which is 50.00% down from last year.
  • Per Sarepta Therapeutics' latest filing, its Other financing activities stood at $716,000 for FY2022, which was down 50.00% from $1.4 million recorded in FY2021.
  • Sarepta Therapeutics' Other financing activities' 5-year high stood at $9.1 million during FY2019, with a 5-year trough of $716,000 in FY2022.
  • Moreover, its 3-year median value for Other financing activities was $1.4 million (2021), whereas its average is $2.8 million.
  • In the last 5 years, Sarepta Therapeutics' Other financing activities climbed by 0.82% in 2019 and then slumped by 77.39% in 2021.
  • Sarepta Therapeutics' Other financing activities (Yearly) stood at $9.1 million in 2018, then increased by 0.82% to $9.1 million in 2019, then tumbled by 30.67% to $6.3 million in 2020, then crashed by 77.39% to $1.4 million in 2021, then plummeted by 50.00% to $716,000 in 2022.